We are live on ! Find out more
NVOS

Novo Integrated Sciences, Inc. Common Stock
NVOS

Delisted

NVOS was delisted on the 5th of November, 2024.

Back to rankings

9 hedge funds and large institutions have $466K invested in Novo Integrated Sciences, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more funds holding

Funds holding: 8 → 9 (+1)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

41% less capital invested

Capital invested by funds: $792K → $466K (-$326K)

Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$38K
2
TRCT
Tower Research Capital (TRC)
New York
+$9.85K
3
Wells Fargo
Wells Fargo
California
+$16

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$14K
2
BlackRock
BlackRock
New York
-$1.25K
3
UBS Group
UBS Group
Switzerland
-$244
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$269K – – –
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$82K -$14K -859 -10%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$29K – – –
BlackRock
4
BlackRock
New York
$28K -$1.25K -77 -3%
Citadel Advisors
5
Citadel Advisors
Florida
$25K +$38K +2,338 New
State Street
6
State Street
Massachusetts
$22K – – –
TRCT
7
Tower Research Capital (TRC)
New York
$10K +$9.85K +606 +162%
UBS Group
8
UBS Group
Switzerland
$1K -$244 -15 -12%
Wells Fargo
9
Wells Fargo
California
– +$16 +1 +14%

NVOS Hedge Fund Activity: Q3 2022 in Review

9 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Novo Integrated Sciences, Inc. Common Stock (NVOS) for Q3 2022, worth a combined $466K — down 41% from $792K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new NVOS positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $38K. The largest seller was Royal Bank of Canada, cutting an estimated $14K.

  • 9 institutional investors held Novo Integrated Sciences, Inc. Common Stock (NVOS) as of Q3 2022, up from 8 in Q2 2022.
  • Funds reported $466K of Novo Integrated Sciences, Inc. Common Stock stock for Q3 2022, down 41% quarter-over-quarter.
  • 1 fund opened new Novo Integrated Sciences, Inc. Common Stock positions in Q3 2022 and 0 closed out, a net change of +1 holder.
  • The largest Novo Integrated Sciences, Inc. Common Stock buyer in Q3 2022 was Citadel Advisors, an estimated $38K added.
  • The largest Novo Integrated Sciences, Inc. Common Stock seller in Q3 2022 was Royal Bank of Canada, an estimated $14K sold.

Based on aggregated 13F filings for Q3 2022.